Source link : https://newshealth.biz/health-news/adjuvant-pertuzumab-shows-os-benefit-in-breast-cancer/
Adding adjuvant pertuzumab to standard adjuvant chemotherapy and trastuzumab improved overall survival at 11 years of follow-up in patients with early human epidermal growth factor receptor 2 (HER2)–positive operable breast cancer, according to a new analysis of a phase 3 trial. The benefit was driven only by those with node-positive cancer, according to findings presented […]
The post Adjuvant Pertuzumab Shows OS Benefit in Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-19 13:06:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8